Abliva Ab (publ)(FRA) NTP

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

$0.00

+0.00%

+0.00Today

Abliva Ab (publ) Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$4.01

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

NTP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Abliva Ab (publ)

Abliva AB operates as a biopharmaceutical company, which engages in the research and development of medicines for the treatment of primary mitochondrial diseases. Its projects include KL1333 and NV354. The company was founded by Eskil Elmer on February 1, 2000 and is headquartered in Lund, Sweden.

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ellen K. Donnelly, PhD

Website

www.abliva.com

NTP Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Abliva Ab (publ) Performance Analysis

Abliva Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 14,881	N/A
2022	2022-12-31	USD 2,915	-80.4%
2023	2023-12-31	USD 11,937	309.5%
2024	2024-12-31	USD 0	N/A

Abliva Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -0.03	N/A
2022	2022-12-31	USD -0.01	-66.4%
2023	2023-12-31	USD -0.01	-26.9%
2024	2024-12-31	USD -0.01	-26.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$0.04

N/A

Gross Margin

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$2.30

N/A

EBITDA

-$2.35

N/A

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Total Cash

$2.87

N/A

Total Debt

$0.01

N/A

Accounts Receivable

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.01

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-110.00%

N/A

Return on Invested Capital

-122.18%

N/A

Free Cash Flow

-$3.27

N/A

Operating Cash Flow

-$1.15

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About NTP

What is the current price of Abliva Ab (publ)?

Abliva Ab (publ) is trading at N/A per share.

What is the 52-week range for Abliva Ab (publ)?

Over the past 52 weeks, Abliva Ab (publ) has traded between N/A and N/A.

How much debt does Abliva Ab (publ) have?

As of the most recent reporting period, Abliva Ab (publ) reported total debt of $9.63K.

How much cash does Abliva Ab (publ) have on hand?

Abliva Ab (publ) reported $2.86M in cash and cash equivalents in its most recent financial results.

What is Abliva Ab (publ)’s dividend yield?

Abliva Ab (publ) does not currently have a dividend yield.

Abliva Ab (publ)(FRA) NTP

Abliva Ab (publ) Financials at a Glance

NTP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Abliva Ab (publ)

NTP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Abliva Ab (publ) Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NTP

What is the current price of Abliva Ab (publ)?

What is the 52-week range for Abliva Ab (publ)?

How much debt does Abliva Ab (publ) have?

How much cash does Abliva Ab (publ) have on hand?

What is Abliva Ab (publ)’s dividend yield?

Premium Investing Services